3-Methoxybenzaldehyde → HCID 135886508, compound

HRID 2424820Notes

Reaction equation

[CH3:1][C@@H:2]1[CH2:6][N:5]([CH2:7][C:8]2[CH:9]=NC(C)=N[CH:13]=2)[CH2:4][C@H:3]1[C:15]1[NH:16][C:17](=[O:30])[C:18]2[CH:23]=[N:22][N:21]([CH:24]3[CH2:29][CH2:28][O:27][CH2:26][CH2:25]3)[C:19]=2[N:20]=1.C([BH3-])#N.[Na+].[CH3:35][O:36][C:37]1C=C(C=[CH:43][CH:44]=1)C=O>>[CH3:35][O:36][C:37]1[CH:9]=[C:8]([CH:13]=[CH:43][CH:44]=1)[CH2:7][N:5]1[CH2:6][C@@H:2]([CH3:1])[C@H:3]([C:15]2[NH:16][C:17](=[O:30])[C:18]3[CH:23]=[N:22][N:21]([CH:24]4[CH2:25][CH2:26][O:27][CH2:28][CH2:29]4)[C:19]=3[N:20]=2)[CH2:4]1

Participants

Reactant 3

HCID 115693-Methoxybenzaldehyde

HCID 5003444Sodium cyanoborohydride

HCID 1358864606-((3S,4S)-4-Methyl-1-((2-methylpyrimidin-5-YL)methyl)pyrrolidin-3-YL)-1-(tetrahydro-2H-pyran-4-YL)-1,5-dihydro-4H-pyrazolo[3,4-D]pyrimidin-4-one

Product 1

HCID 135886508HCID 135886508, compound

Procedure

Following the procedure for the preparation of 6-{(3S,4S)-4-methyl-1-[(2-methylpyrimidin-5-yl)methyl]pyrrolidin-3-yl}-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one but substituting sodium cyanoborohydride and 3-methoxybenzaldehyde provided the title compound. 400 MHz 1H NMR (CDCl3) δ 8.02 (s, 1H), 7.27-7.21 (m, 1H), 6.96-6.92 (m, 2H), 6.81 (d, J=7.1 Hz, 1H), 4.82-4.76 (m, 1H), 4.14-4.08 (m, 2H), 3.85 (s, 3H), 3.79 (s, 1H), 3.62-3.54 (m, 3H), 3.39 (t, J=8.7 Hz, 1H), 3.00 (d, J=10.3 Hz, 1H), 2.81 (m, 1H), 2.53 (m, 1H), 2.42-2.28 (m, 3H), 1.94-1.82 (m, 3H), 1.20 (d, J=7.1 Hz, 3H). MS: (M+H m/z 424.1).

Sources & evidence

ORD record: ord-b4fe8dfee42f448b94223d332403f1a3
Source dataset: uspto-grants-2011_06
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US07964607B2

Reaction notes

Loading…